Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia
Ezaki, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 279-284
2000
ISSN/ISBN: 0385-0684 PMID: 10895166 Document Number: 513796
Document emailed within 1 workday
Related Documents
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334Guilhot, F. 1993: Interferon alfa and low-dose cytosine-arabinoside for the treatment of patients with chronic myelogenous leukemia in chronic phase. French CML Study Group Seminars in Hematology 30(3 Suppl 3: 24-25
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Takemoto, Y.; Sampi, K.; Kuraishi, Y.; Okabe, K.; Tamura, K.; Mizoguchi, H.; Saito, H.; Masaoka, T.; Ogawa, M. 1999: A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. the KRN8602 Leukemia Study Group International Journal of Hematology 70(1): 20-25
Molnár, L.; Nagy, A.; Dávid, M.; Szomor, A.ád.; Méhes, G.áb.; Kovács, G.áb.; Losonczy, H. 2004: Results of imatinib therapy in late-stage chronic myeloid leukemia after treatment with interferon-alpha Orvosi Hetilap 145(17): 901-907
Guilhot, F.; Guerci, A.; Fiere, D.; Harousseau, J.L.; Maloisel, F.; Bouabdallah, R.; Guyotat, D.; Rochant, H.; Najman, A.; Nicolini, F.; Colombat, P.; Abgrall, J.F.; Ifrah, N.; Brière, J.; Bauters, F.; Navarro, M.; Morice, P.; Bordessoule, D.; Vilque, J.P.; Desablens, B.; Tertian, G.; Blanc, M.; Chastang, C.; Tanzer, J. 1996: The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group Bone Marrow Transplantation 17(Suppl 3): S29-S31
Pedersen, G.; Stentoft, J.; Pedersen, J.O.; Jensen, M.K. 1994: Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside Ugeskrift for Laeger 156(43): 6380-6384
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Wächter, M.; Goldschmidt, H.; Blau, W.; Elstner, E.; Ihle, R. 1988: Effect of cytosine arabinoside on the differentiation of granulocyte-monocyte progenitors (CFU-GM) and myeloid leukemia blasts (CFU-L) in vitro Folia Haematologica 115(6): 927-934
Harakati, M.S. 1999: Cytosine arabinoside, mitoxantrone, and etoposide in the treatment of adult patients with previously untreated acute myeloid leukemia Saudi Medical Journal 20(4): 291-295
Xu, P-Pei.; Chen, B-An.; Feng, J-Feng.; Cheng, L.; Xia, G-Hua.; Li, Y-Feng.; Qian, J.; Ding, J-Hua.; Lu, Z-Hong.; Wang, X-Mei.; Xu, K.; Schultz, M. 2012: Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia Chinese Medical Journal 125(12): 2137-2143
Cannistra, S.A.; DiCarlo, J.; Groshek, P.; Kanakura, Y.; Berg, D.; Mayer, R.J.; Griffin, J.D. 1991: Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia Leukemia 5(3): 230-238
Faber, E.; Jarosová, M.; Divoký, V.; Luhový, M.; Komenda, S.; Sulovská, I.; Hubácek, J.; Slezák, P.; Papajik, T.; Raida, L.; Heczko, M.; Indrák, K. 1997: Interferon-alpha in the treatment of patients with chronic myeloid leukemia Vnitrni Lekarstvi 43(1): 13-17
Ladoyanni, E.; Nambi, R. 2005: Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia Journal of Drugs in Dermatology: Jdd 4(2): 221-222
Zuffa, E.; Bandini, G.; Bonini, A.; Santucci, M.A.; Martinelli, G.; Rosti, G.; Testoni, N.; Zaccaria, A.; Tura, S. 1998: Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia Haematologica 83(3): 231-236
Baran, Y.; Gunduz, U.; Ural, A.U. 2006: Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine Experimental Oncology 28(2): 163-165
Soppi, E.; Lahtinen, R. 1988: Salmonella-induced reactive arthritis in a chronic myeloid leukemia patient on hydroxyurea and interferon-alpha Clinical and Experimental Rheumatology 6(4): 425-426
Ohshima, A.; Yoshida, K.; Sato, T.; Miyazaki, S.; Yanagisawa, M.; Nakayama, Y.; Takahashi, T.; Mamiya, S.; Fukusima, Y.; Miura, A.B. 1987: Intermediate- and high-dose cytosine arabinoside therapy in acute refractory leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(1): 192-195
Bodey, G.P.; Rodriguez, V.; Hart, J.; Freireich, E.J. 1970: Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271) Cancer ChemoTherapy Reports 54(4): 255-262
Tran, A.; Longo, F.; Saint-Paul, M.C.; Doglio, A.; Benzaken, S.; Rampal, P. 2000: Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study Gastroenterologie Clinique et Biologique 24(12): 1234-1235